Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Somnath Sarkar

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|September 19, 2006
Quantifying the treatment effect explained by markers in the presence of measurement errorSomnath Sarkar, Yongming Qu
Organic & Biomolecular Chemistry|February 9, 2022
A Zn(II)-functionalized COF as a recyclable catalyst for the sustainable synthesis of cyclic carbonates and cyclic carbamates from atmospheric CO<sub>2</sub>Somnath Sarkar, Swarbhanu Ghosh, Sk Manirul Islam
Indian Journal of Dermatology|March 9, 2016
Dermatofibroma: Atypical PresentationsMousumi Roy Bandyopadhyay, Mrinal Besra, Somasree Dutta, et al.
Chemical Communications (Cambridge, England)|September 14, 2020
Cu/Cu<sub></sub>O<sub></sub> NPs architectured COF: a recyclable catalyst for the synthesis of oxazolidinedione <i>via</i> atmospheric cyclizative CO<sub>2</sub> utilizationSomnath Sarkar, Swarbhanu Ghosh, Jahangir Mondal, et al.
Statistics in Biopharmaceutical Research|August 23, 2019
Borrowing from Historical Control Data in Cancer Drug Development: A Cautionary Tale and Practical GuidelinesConnor Jo Lewis, Somnath Sarkar, Jiawen Zhu, et al.
Contemporary Clinical Trials|November 20, 2019
An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphomaJames Normington, Jiawen Zhu, Federico Mattiello, et al.
Current Medical Research and Opinion|July 22, 2004
Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal womenDavid A Cox, Somnath Sarkar, Kristine Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trialsFairooz F Kabbinavar, Herbert I Hurwitz, Jing Yi, et al.
Contemporary Clinical Trials|May 17, 2021
Rolling continual reassessment method with overdose control: An efficient and safe dose escalation designJiawen Zhu, Daniel Sabanés Bové, Ziwei Liao, et al.
Obstetrics and Gynecology|October 2, 2004
Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluationDeborah Grady, Bruce Ettinger, Elena Moscarelli, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|September 19, 2006
Quantifying the treatment effect explained by markers in the presence of measurement errorSomnath Sarkar, Yongming Qu
Organic & Biomolecular Chemistry|February 9, 2022
A Zn(II)-functionalized COF as a recyclable catalyst for the sustainable synthesis of cyclic carbonates and cyclic carbamates from atmospheric CO<sub>2</sub>Somnath Sarkar, Swarbhanu Ghosh, Sk Manirul Islam
Indian Journal of Dermatology|March 9, 2016
Dermatofibroma: Atypical PresentationsMousumi Roy Bandyopadhyay, Mrinal Besra, Somasree Dutta, et al.
Chemical Communications (Cambridge, England)|September 14, 2020
Cu/Cu<sub></sub>O<sub></sub> NPs architectured COF: a recyclable catalyst for the synthesis of oxazolidinedione <i>via</i> atmospheric cyclizative CO<sub>2</sub> utilizationSomnath Sarkar, Swarbhanu Ghosh, Jahangir Mondal, et al.
Statistics in Biopharmaceutical Research|August 23, 2019
Borrowing from Historical Control Data in Cancer Drug Development: A Cautionary Tale and Practical GuidelinesConnor Jo Lewis, Somnath Sarkar, Jiawen Zhu, et al.
Contemporary Clinical Trials|November 20, 2019
An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphomaJames Normington, Jiawen Zhu, Federico Mattiello, et al.
Current Medical Research and Opinion|July 22, 2004
Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal womenDavid A Cox, Somnath Sarkar, Kristine Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trialsFairooz F Kabbinavar, Herbert I Hurwitz, Jing Yi, et al.
Contemporary Clinical Trials|May 17, 2021
Rolling continual reassessment method with overdose control: An efficient and safe dose escalation designJiawen Zhu, Daniel Sabanés Bové, Ziwei Liao, et al.
Obstetrics and Gynecology|October 2, 2004
Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluationDeborah Grady, Bruce Ettinger, Elena Moscarelli, et al.
Pageof 3